When Should Children With DMD Start ACE Inhibitors?

When a child is diagnosed with Duchenne muscular dystrophy (DMD), the care team will monitor their heart health closely. Current consensus guidelines suggest that doctors should consider starting a medication called an ACE inhibitor—or a related medicine called an ARB—by around age 10 ^[1][2]. While this age is a general target, the exact timing is highly individualized. The cardiologist may recommend starting earlier if sensitive tests show early tissue changes in the heart, or they may adjust the timeline based on blood pressure, kidney function, and other factors ^[3][4].

ACE inhibitors and ARBs are different classes of medications that work on the same hormone system to relax blood vessels and reduce the workload on the heart. If a child develops a persistent cough from an ACE inhibitor, the doctor may switch them to an ARB. This early, proactive use of medication before symptoms appear is called prophylactic treatment, and its goal is to reduce the risk of future heart problems ^[5][6].

The “Silent” Progression of Heart Damage

It is completely natural to feel hesitant about starting a daily medication when your child seems fine. However, in DMD, the heart is a muscle that lacks dystrophin, just like the muscles in the arms and legs. Over time, heart muscle cells can experience stress and may gradually be replaced by scar tissue, a process called myocardial fibrosis ^[4].

Because children with DMD often have limited physical mobility, they do not exert their hearts the way other children might during intense sports. As a result, classic signs of a struggling heart—such as breathlessness or extreme fatigue during exercise—may not be obvious right away ^[7]. Cardiac disease can be present without outward symptoms, and microscopic changes can begin in the heart tissue even when routine tests, like an echocardiogram (an ultrasound of the heart), show normal pumping function ^[4].

The Benefits of Proactive Medication

Modern cardiac care for DMD focuses on prevention rather than waiting for heart failure to develop. Research supports this proactive approach:

• Slowing heart changes: A two-year randomized study of patients with DMD and Becker muscular dystrophy who had early signs of fibrosis (but normal pumping function) found that those taking an ACE inhibitor had slower progression of scar tissue compared to those not taking the medication (a 3.1% increase in left-ventricular mass versus a 10.0% increase) ^[3].
• Delaying heart dysfunction: Observational studies suggest that starting prophylactic medication before there is a documented drop in the heart’s pumping ability is associated with a delayed onset of heart dysfunction later on ^[5].
• Improving long-term outcomes: Data from patient registries show an association between the proactive use of ACE inhibitors and a lower risk of overall mortality and heart failure hospitalizations ^[6]. While observational data cannot guarantee a specific outcome for every child, it strongly supports the protective role of these medicines.

Ongoing Surveillance and Medication Safety

Cardiac screening should begin at diagnosis and continue regularly, not just after medication starts. Guidelines generally recommend at least annual assessments, but the schedule depends on your child’s age and test results ^[8].

Screening typically includes an electrocardiogram (ECG) to check the electrical rhythm and an echocardiogram to check pumping function ^[8]. Increasingly, doctors also use a cardiac MRI (CMR) because it is highly sensitive and can detect early tissue changes ^[8][4]. However, a baseline MRI is not always required or feasible for every young child, as it requires staying very still and sometimes needs sedation.

Medication Monitoring: Before starting an ACE inhibitor or ARB, and after any dose changes, the care team will check blood pressure and run blood tests to monitor kidney function and potassium levels ^[9][10].

• Common side effects to watch for include dizziness, low blood pressure, or a dry cough (which is specific to ACE inhibitors).
• Emergency signs: Rarely, these medications can cause a severe allergic reaction with swelling of the lips, tongue, or face, which requires immediate emergency care.
• Never stop or change the medication dose without consulting your cardiologist, and always ask for a plan on what to do during illnesses that cause vomiting or dehydration.